Manufacture for sale, sale or distribution for human use of certain drug fixed dose combinations prohibited
In exercise of powers under the Drugs and Cosmetics Act, 1940, the Central Government has prohibited the manufacture for sale, sale or […]
Public comments invited by the Health Ministry on the draft New Drugs and Clinical Trials (Amendment) Rules, 2022 till 7th December, 2022
The Ministry of Health has proposed New Drugs and Clinical Trials (….Amendment) Rules, 2022 with a view to further amend the New […]
Drugs Rules, 1945 amended to expand the list of permissible colours that may be used for disinfectants
The Health Ministry has amended the Drugs Rules, 1945 to notify the permissible colours which may be used for disinfectants. Now, in […]
Amendments underway to the Drugs Rules, 1945; proposes to cast compliance obligations upon drug manufacturers to affix Bar Codes and Quick Response Codes on labels of specific drugs from 1st May, 2023;public comments invited till 14th July, 2022
The Ministry of Health and Family Welfare (“Ministry”) has proposed draft amendments to the Drugs Rules, 1945. The draft (Amendment) Rules propose […]
Amendments underway to the Drugs Rules; proposes parallel submission of applications for grant of renewal of manufacturing and sales license for large volume parenterals, vaccines and (r-DNA) derived drugs etc. comments invited till 22.06.202
Ministry of Health and Family Welfare has proposed further amendments to the Drug Rules, 1945. The draft Rules propose to introduce a […]
Health Ministry notifies the Drugs (3rd Amendment) Rules, 2022; introduces new colour ‘Allura Red’ to list of colours permitted to be used in drugs
In continuation to what we reported earlier (please refer to trailing e-mail), the Health Ministry has issued the Drugs (3rd Amendment) Rules, […]
Public comments invited on the draft amendments to the New Drugs and Clinical Trials Rules by 5th Feb, 2022; proposes to introduce deemed approval w.r.t. registration of Ethics Committee, conducting all clinical trials etc.
The Ministry of Health has proposed a draft of the New Drugs and Clinical Trials (……Amendment) Rules, 2022 (“Draft Rules“) to further […]